HM Payson & Co. Has $1.19 Million Position in GE HealthCare Technologies Inc. $GEHC

HM Payson & Co. cut its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 32.0% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 15,863 shares of the company’s stock after selling 7,461 shares during the period. HM Payson & Co.’s holdings in GE HealthCare Technologies were worth $1,191,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Allianz SE boosted its position in shares of GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after acquiring an additional 218 shares during the period. Gladwyn Financial Advisors Inc. acquired a new position in shares of GE HealthCare Technologies during the 2nd quarter worth approximately $34,000. Game Plan Financial Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 295.3% during the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after purchasing an additional 375 shares during the period. N.E.W. Advisory Services LLC raised its position in shares of GE HealthCare Technologies by 75.2% in the second quarter. N.E.W. Advisory Services LLC now owns 545 shares of the company’s stock valued at $40,000 after buying an additional 234 shares in the last quarter. Finally, HFM Investment Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the first quarter valued at approximately $60,000. Institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the topic of a number of analyst reports. Wells Fargo & Company reduced their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research report on Thursday, October 30th. Evercore ISI increased their target price on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Stifel Nicolaus set a $90.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 22nd. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $87.09.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $83.15 on Tuesday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The stock’s 50-day simple moving average is $78.89 and its 200 day simple moving average is $75.91. The firm has a market capitalization of $37.88 billion, a PE ratio of 17.18, a price-to-earnings-growth ratio of 3.49 and a beta of 1.09.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same quarter in the prior year, the business earned $1.14 earnings per share. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be given a $0.035 dividend. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.